Two-vaccine Ebola regimen shows promise in early-stage clinical trial
An immunization regimen using two Ebola vaccine candidates was safe and well-tolerated and induced an immune response in healthy adult volunteers in a Phase 1 clinical trial. Results from the study are described in the April 19th issue of the Journal of the American Medical Association.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: American Medical Association (AMA) | Clinical Trials | Ebola | Ebola Vaccine | Pharmaceuticals | Study | Vaccines